Articles by Stephanie Sutton - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Stephanie Sutton

News

Aug 1, 2012

Pharmacovigilance rules enter into effect.

Medicines Top EU's Counterfeit List

Jul 30, 2012

A report from the European Commission shows that fake pharmaceuticals were the top articles detained by European Union customs in 2011.

EC Investigates Lundbeck for Potential Pay-to-Delay Agreements

Jul 27, 2012

The European Commission has issued a statement of objections against Lundbeck and several other pharmaceutical companies with the preliminary view that Lundbeck formed agreements with generic-drug companies to prevent the market entry of cheaper versions of its antidepressant, citalopram.

UK Consults on Early Medicines Access

Jul 23, 2012

The UK's Medicines and Healthcare products Regulatory Agency has launched a public consultation regarding a scheme that could provide patients with access to unlicensed medicines in Phase II or III clinical trials.

EC Offers Aid to Former AstraZeneca Workers

Jul 20, 2012

The European Commission is looking to provide Sweden with EUR4.3 million to help 700 workers affected by AstraZeneca job cuts to find new work.

Analytical Tools for a Quality-by-Design Approach to Lyophilization

Experts share insights into analytical tools and techniques.
Jul 18, 2012

Experts share insights into analytical tools and techniques.

GSK to Acquire Human Genome Sciences for $3.6 Billion

Jul 18, 2012

GlaxoSmithKline has announced that it will acquire Human Genome Sciences (HGS) for $14.25 per share in cash, or approximately $3.6 billion on an equity basis.

35th Anniversary Special: Reader Views on Changes in Pharmaceutical Manufacturing

Readers point to quality by design as having a significant influence on manufacturing and drug development during the past decade.
Jul 2, 2012

Readers point to quality by design as having a significant influence on manufacturing and drug development during the past decade.

Lyophilization: How to Meet Scale-Up Challenges Using QbD

Experts share how to choose analytical tools and techniques when scaling up a lyophilization process.
Jul 2, 2012

Experts share how to choose analytical tools and techniques when scaling up a lyophilization process.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here